Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tivanisiran, a novel siRNA for the treatment of dry eye disease.
Moreno-Montañés J, Bleau AM, Jimenez AI. Moreno-Montañés J, et al. Expert Opin Investig Drugs. 2018 Apr;27(4):421-426. doi: 10.1080/13543784.2018.1457647. Epub 2018 Mar 29. Expert Opin Investig Drugs. 2018. PMID: 29569947 Review.
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease.
Benitez-Del-Castillo JM, Moreno-Montañés J, Jiménez-Alfaro I, Muñoz-Negrete FJ, Turman K, Palumaa K, Sádaba B, González MV, Ruz V, Vargas B, Pañeda C, Martínez T, Bleau AM, Jimenez AI. Benitez-Del-Castillo JM, et al. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6447-6454. doi: 10.1167/iovs.16-20303. Invest Ophthalmol Vis Sci. 2016. PMID: 27893109 Free article. Clinical Trial.
siRNA Therapeutics in Ocular Diseases.
Moreno-Montañés J, Bleau AM, Martínez T, Vargas B, González MV, Jiménez AI. Moreno-Montañés J, et al. Methods Mol Biol. 2021;2282:417-442. doi: 10.1007/978-1-0716-1298-9_23. Methods Mol Biol. 2021. PMID: 33928588 Review.
134 results